Fulton Bank, N.A. Catalent, Inc. Transaction History

Fulton Bank, N.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 04, 2024	SELL	$32.18 - $46.57 $2,799 - $4,051	-87 Reduced 1.76%	4,854 $218,000
Q3 2023 Oct 04, 2023	BUY	$44.2 - $50.2 $218,392 - $248,038	4,941 New	4,941 $224,000
Q1 2023 Apr 06, 2023	BUY	$45.44 - $74.26 $225,973 - $369,294	4,973 New	4,973 $326,000
Q3 2022 Oct 04, 2022	BUY	$72.36 - $113.1 $90,956 - $142,166	1,257 Added 37.66%	4,595 $333,000
Q2 2022 Jul 07, 2022	BUY	$87.2 - $114.05 $291,073 - $380,698	3,338 New	3,338 $359,000

216

73.2M

477K

2.02M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Fulton Bank, N.A. with notifications on news.